TRIM31
E3 ubiquitin-protein ligase TRIM31
Also known as: C6orf13, HCG1, HCGI, RNF, TRI31_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZY9
- Gene
- TRIM31
- Ensembl
- ENSG00000204616
- Chromosome
- 6
- Canonical length
- 425 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein that functions as an E3 ubiquitin-protein ligase. This gene shows altered expression in certain tumors and may be a negative regulator of cell growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
425 residues, UniProt reviewed canonical sequence.
>Q9BZY9|TRIM31
1 MASGQFVNKL QEEVICPICL DILQKPVTID CGHNFCLKCI TQIGETSCGF FKCPLCKTSV
61 RKNAIRFNSL LRNLVEKIQA LQASEVQSKR KEATCPRHQE MFHYFCEDDG KFLCFVCRES
121 KDHKSHNVSL IEEAAQNYQG QIQEQIQVLQ QKEKETVQVK AQGVHRVDVF TDQVEHEKQR
181 ILTEFELLHQ VLEEEKNFLL SRIYWLGHEG TEAGKHYVAS TEPQLNDLKK LVDSLKTKQN
241 MPPRQLLEDI KVVLCRSEEF QFLNPTPVPL ELEKKLSEAK SRHDSITGSL KKFKDQLQAD
301 RKKDENRFFK SMNKNDMKSW GLLQKNNHKM NKTSEPGSSS AGGRTTSGPP NHHSSAPSHS
361 LFRASSAGKV TFPVCLLASY DEISGQGASS QDTKTFDVAL SEELHAALSE WLTAIRAWFC
421 EVPSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM31 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- colon: 21 nTPM
- urinary bladder: 16 nTPM
- small intestine: 11 nTPM
- stomach: 5.6 nTPM
- testis: 3.2 nTPM
- prostate: 1.9 nTPM
Single-cell type
- urothelial cells: 65 nCPM
- prostatic club cells: 21 nCPM
- prostatic hillock cells: 18 nCPM
- colonocytes: 15 nCPM
- papillary tip epithelial cells: 14 nCPM
- enterocytes: 11 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- defense response to virus
- host-mediated suppression of symbiont invasion
- inflammatory response
- innate immune response
- negative regulation of NLRP3 inflammasome complex assembly
- negative regulation of viral transcription
- protein K48-linked ubiquitination
- protein K63-linked ubiquitination
- ubiquitin-dependent protein catabolic process
- viral release from host cell
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIM31 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM31 as an antibody target. Whether an autoantibody or antibody against TRIM31 could matter depends on whether native TRIM31 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM31 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM31 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...